Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

National Cancer Institute to sponsor phase I study of Reolysin in multiple myeloma

May 11, 2011

Roche seeks FDA and EMA approval for vemurafenib in metastatic melanoma

May 11, 2011

AstraZeneca discloses preclinical data on AZD-5363, in phase I testing in solid tumors

May 11, 2011

Albany Medical School and Aegis Therapeutics join to develop peptide against breast cancer

May 11, 2011

Cephalon begins phase I/II CEP-9722 trial in advanced solid tumors

May 11, 2011

Merck & Co. patents new inhibitors of Mdm2-p53 interaction

May 11, 2011

Bayer's regorafenib receives FDA fast track status in GIST

May 10, 2011

Wilex completes patient recruitment in phase II Mesupron trial

May 10, 2011

Astellas and Medivation begin new phase II MDV-3100 trial in prostate cancer

May 10, 2011

New ALK tyrosine kinase receptor inhibitors presented

May 10, 2011

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...